67 related articles for article (PubMed ID: 35758181)
1. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease.
Sweeney JR; Crawford CV; Yantiss RK
Histopathology; 2022 Sep; 81(3):312-318. PubMed ID: 35758181
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
[TBL] [Abstract][Full Text] [Related]
3. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
[TBL] [Abstract][Full Text] [Related]
4. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
[TBL] [Abstract][Full Text] [Related]
5. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
Dalal RS; Allegretti JR
Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
[TBL] [Abstract][Full Text] [Related]
7. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
Reasoner SA; Nicholson MR
Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
[TBL] [Abstract][Full Text] [Related]
8. Rare Clinical Association between
Ionescu EM; Curte AM; Olteanu AO; Preda CM; Tieranu I; Klimko A; Tieranu CG
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356986
[No Abstract] [Full Text] [Related]
9. How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
Houri H; Yadegar A; Zali MR
Dig Dis Sci; 2021 Sep; 66(9):2849-2850. PubMed ID: 33094453
[No Abstract] [Full Text] [Related]
10. Host Sorbitol and Bacterial Sorbitol Utilization Promote Clostridioides difficile Infection in Inflammatory Bowel Disease.
Yang Z; Qin J; Zhao L; Chen T; Huang Q; Jian Y; Zhao Q; Yang S; Li Q; Liu Q; Otto M; Li M
Gastroenterology; 2023 Jun; 164(7):1189-1201.e13. PubMed ID: 36898551
[TBL] [Abstract][Full Text] [Related]
11. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Varma S; Trudeau SJ; Li J; Freedberg DE
Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
[TBL] [Abstract][Full Text] [Related]
12. The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.
Peng JC; Shen J; Zhu Q; Ran ZH
Saudi J Gastroenterol; 2015; 21(4):208-12. PubMed ID: 26228363
[TBL] [Abstract][Full Text] [Related]
13. A Rare Case of Polymerase Chain Reaction-Negative Severe Clostridioides difficile Infection.
Iheagwara CC; Cantu Lopez C; Otaluka ON; Okwesili B; Belinski V; Muhanna A; Tewoldemedhin B; Slim J; Szabela M; Boghossian J; Bains Y
Cureus; 2023 Dec; 15(12):e50403. PubMed ID: 38213357
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Associated with
Martinez E; Crevecoeur S; Thirion C; Grandjean J; Fall PA; Hayette MP; Michel M; Taminiau B; Louis E; Daube G
Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894185
[No Abstract] [Full Text] [Related]
15. A Case of
Tekin S; İrkören P; Sucu S; Kartal K
Infect Dis Clin Microbiol; 2022 Dec; 4(4):293-298. PubMed ID: 38633715
[No Abstract] [Full Text] [Related]
16. Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.
Kuo J; Uzunovic J; Jacobson A; Dourado M; Gierke S; Rajendram M; Keilberg D; Mar J; Stekol E; Curry J; Verstraete S; Lund J; Liang Y; Tamburini FB; Omattage NS; Masureel M; Rutherford ST; Hackos DH; Tan MW; Byrd AL; Keir ME; Skippington E; Storek KM
J Crohns Colitis; 2024 Jan; ():. PubMed ID: 38267224
[TBL] [Abstract][Full Text] [Related]
17. Takotsubo Syndrome and Colitis Due to Clostridium difficile: Is There a Relationship?
Haydar M; Levinger U; Habib G
Isr Med Assoc J; 2024 Mar; 26(3):193-195. PubMed ID: 38493333
[No Abstract] [Full Text] [Related]
18. Vancomycin in the treatment of inflammatory bowel disease: there is a role beyond Clostridioides difficile infection.
Calderón P; Damas O; Nuñez P; Quera R
Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882174
[TBL] [Abstract][Full Text] [Related]
19. Findings and Prognosis in 149 Horses with Histological Changes Compatible with Inflammatory Bowel Disease.
Kranenburg LC; Bouwmeester BF; van den Boom R
Animals (Basel); 2024 May; 14(11):. PubMed ID: 38891685
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
